Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.125 (11.11%)
Bid:
1.20
Ask:
1.25
Spread: 0.05 (4.167%)
Market Cap: £29.32m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Open Offer

3 Dec 2009 07:00

RNS Number : 5044D
Provexis PLC
03 December 2009
Β 

ο»Ώ

Provexis plcΒ 

Β 

Open Offer of up to 85,211,664 new Ordinary Shares at 2.5 pence per share

on the basis of 1 Offer Share for every 12 Existing Shares with Excess Application Facility

The Board of Provexis today announcesΒ that it proposes to raise up to approximately Β£2.1 million (before expenses) by way of an Open Offer. The Open Offer follows the completion of the Subscription by the Company, as announced on 25 September 2009. The Company is able to undertake the Open Offer within the authorities that were approved by Shareholders at the annual general meeting of the Company held on 15 October 2009. There is no requirement for Shareholders to vote on the Open Offer. Qualifying Shareholders may subscribe for Offer Shares above their basicΒ pro rataΒ Open Offer Entitlements if they so wish under the Excess Application Facility.Β 

Reasons for the Open Offer

The Company announced on 25 September 2009 a subscription by new and existing shareholders of 200,000,000 new Ordinary Shares at a price of 2.5p per share to raise Β£5 million before commission and expenses. The subscription price represented a discount of approximately 72.2 per cent. to the closing mid-market price of 9 pence per Ordinary Share on 24 September 2009, being the last dealing day prior to the announcement of the Subscription.Β 

While the Directors believed the Subscription to be in the best interests of the Company and Shareholders as a whole, they considered it appropriate that all Shareholders should be offered the opportunity to participate at the same price per share as those subscribing for the Subscription. At the time of the Subscription an offer to existing Shareholders by way of a rights or other pre-emptive issue was not practicable or feasible due to the delays that would be incurred.Β 

Following the completion of the Subscription, the Directors are now able to proceed with an open offer to allow Shareholders to invest in the Company at the same price per share as those subscribing in the Subscription.

Details of the Open Offer

Qualifying Shareholders are invited to apply for Offer Shares under the Open Offer at a price of 2.5 pence per Offer Share, payable in full on application and free of all expenses,Β pro rataΒ to their existing shareholdings on the basis of:

1 Offer Share for every 12 Existing Ordinary Shares

held at the Open Offer Record Date. Entitlements of Qualifying Shareholders will be rounded down to the nearest whole number of Offer Shares. Fractional entitlements which would have otherwise arisen will not be issued. The OpenΒ Offer is subject toΒ Admission becoming effective by 8.00 a.m. 22 December 2009 (or such later date being not later than 8.00 a.m.Β onΒ 30 December 2009, as the Company may decide).Β 

The Offer Shares will, when issued and fully paid, rankΒ pari passuΒ in all respects with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of Admission.Β 

The Offer Shares have not been placed subject to clawback nor have they been underwritten. Consequently, there may be either no Offer Shares or fewer than 85,211,664 Offer Shares issued pursuant to the Open Offer.Β 

The Open Offer has been structured so as to allow Qualifying Shareholders to subscribe for Ordinary Shares at the Offer PriceΒ pro rataΒ to their existing holdings. Qualifying Shareholders may, in addition, make applications in excess of their basicΒ pro rataΒ Open Offer Entitlements.Β Once subscriptions under the basicΒ pro rataΒ Open Offer Entitlements have been satisfied, the Company shall scale back any excess applications on aΒ pro rataΒ basis in proportion to the total number of Excess Shares applied for under the Excess Application Facility. To the extent that Offer Shares are not subscribed by Qualifying Shareholders, Open Offer entitlements will lapse.Β 

Subject to availability, the Excess Application Facility enables Qualifying Shareholders to apply for any whole number of Excess Shares in excess of their Basic Entitlement.Β Β Qualifying Non-CREST Shareholders who wish to apply to subscribe for more than their Basic Entitlement should complete the relevant sections on the Non-CREST Application Form. Qualifying CREST Shareholders will have Excess CREST Open Offer Entitlements credited to their stock account in CREST.Β The Excess Application Facility enables Qualifying CREST Shareholders to apply for Excess Shares in excess of their Basic Entitlement up to a maximum number of Excess Shares equal to ninety times the number of Existing Shares registered in their name as at the Record Date.Β If however Qualifying CREST Shareholders wish to apply for more than ninety times the number of Existing Shares registered in their name as at the Record Date, up to the maximum number of shares available under the Open Offer the Qualifying CREST ShareholderΒ should contact Equiniti directly.Β Excess applications may be allocated in such manner as the Directors determine, in their absolute discretion, and no assurance can be given that applications by Qualifying Shareholders under the Excess Application Facility will be met in full or in part or at all.Β 

PLEASE NOTE: Qualifying Shareholders can apply for as few or as many Offer Shares as they wish but will only be guaranteed to receive their basicΒ pro rataΒ Open Offer Entitlement. Excess applications may be fulfilled entirely or may be scaled back depending on Qualifying Shareholder demand.

Settlement and dealings

Application will be made to the London Stock Exchange for the Offer Shares to be admitted to trading on AIM. It is expected that such Admission will become effective and that dealings will commence on 22 December 2009.

Current trading

The CompanyΒ has todayΒ announced its unaudited interim results for the six months ended 30Β September 2009.Β 

Action to be taken in respect of the Open Offer

Shareholders (non-CREST)

Qualifying non-CREST ShareholdersΒ willΒ be sentΒ an Application Form which gives details of your basic Open Offer Entitlements (as shown by the number of basicΒ pro rataΒ Open Offer Entitlements allocated to you). IfΒ Qualifying non-CREST ShareholdersΒ wish to apply for Offer Shares under the Open Offer (including additional Excess Shares under the Excess Application Facility),Β theyΒ should complete thisΒ Application Form and post it in the accompanying prepaid envelope, together with payment in full in respect of the number of Offer Shares applied for to Equiniti, so as to arrive as soon as possible and in any event so as to be received no later thanΒ 11.00 a.m. on 21 December 2009.

Qualifying CREST Shareholders

No Application Form will be sent toΒ Qualifying CREST Shareholders, theyΒ will receive a creditΒ in theirΒ appropriate stock account in CREST in respect of the Open Offer Entitlements representingΒ theirΒ basic Open Offer Entitlements and also in respect ofΒ theirΒ Excess CREST Open Offer Entitlements, except (subject to certain exceptions) ifΒ theyΒ are in the United States, or have a registered address in, or are resident in United States, Canada, Japan, Australia or the Republic of South Africa.Β If Qualifying CREST Shareholders wish to apply for more than their Excess CREST Open Offer Entitlement they should contactΒ EquinitiΒ directly.

Qualifying Shareholders can apply for as few or as many Offer Shares as they wish but will only be guaranteed to receive up to their basicΒ pro rataΒ Open Offer Entitlement. Excess applications may be fulfilled entirely or may be scaled back depending on Qualifying Shareholder demand. In the event Excess Applications are scaled back any excess monies will be returned to non-CREST Shareholders by cheque and to CREST Shareholders through CREST.Β 

Qualifying CREST Shareholders who are CREST sponsored members should refer to their CREST sponsors regarding the action to be taken in connection with the Open Offer.

Intentions of the Directors in relation to the Open Offer

A number of the Directors are Qualifying Shareholders and have committed themselves to apply to acquire Offer Shares pursuant to the Open Offer Entitlements attributable to their Existing Ordinary Shares. Details of the Directors' interests in the Existing Ordinary Shares and the number of Offer Shares they intend to subscribe for is set out in the table below:

Number of

Number of

Ordinary Shares

% of Enlarged

Existing

Number of

held

Issued

Ordinary

Offer Shares

following

Share Capital

Name of Director

Shares held

subscribed for

Admission

Mr. Dawson Buck*

10,404,332

867,027

11,271,359

1.0%

Dr. Neville Bain

5,177,000

431,416

5,608,416

0.5%

Mr. Stephen Moon

7,540,000

0

7,540,000

0.7%

Mr. Steven Morrison

1,540,000

128,333

1,668,333

0.2%

Mr. Ian Ford

1,540,000

128,333

1,668,333

0.2%

* Of the 10,404,332 Ordinary Shares that Mr Dawson Buck is interested in 3,581,666 are held by a pension scheme of which Mr DawsonΒ Buck is the beneficiary and 1,540,000 are held by a pension scheme of which a member of the family of Mr Dawson Buck is the beneficiary. The remaining 5,282,666 Ordinary Shares are held directly by Mr Dawson Buck.

Recommendation

The Directors consider the Open Offer to be in the best interests of the Company and its Shareholders as a whole.

Availability of CircularΒ 

Β 

The Circular setting out details of theΒ Open Offer, accompanied by theΒ Application Form (if applicable), is expected to be posted to Qualifying Shareholders today.Β 

Β 

Copies of the Circular will be available for a period of 12 months from the dateΒ of theΒ Circular on the Company's website (www.provexis.com) free of charge in accordance with the requirements of Rule 26 of the AIM Rules.

Terms used in this announcement shall, unless the context otherwise requires, bear the meanings given to them in the Circular.

OPEN OFFER STATISTICSΒ 

Β 

Market price Ordinary Share (1)
7.9 pence
Number of Ordinary Shares in issue at the date of this document
1,022,539,965
Offer Price
2.5 pence
Number of Offer Shares to be offered for subscription by the Company
85,211,664
Estimated maximum gross proceeds of the Open Offer (2)
Β£2.1 million
Number of Ordinary Shares in issue at Admission (2)
1,107,751,629

Percentage of the Enlarged Issue Share Capital represented bythe Offer Shares(2)

7.7%
Β 
Β 

(1) based on the closing mid-market price per Ordinary Shares on 1 December 2009, being the last practicable date prior to the announcement of the Open Offer

(2) assuming maximum take up under the Open Offer

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

2009

Open Offer Record Date and time

5.00 p.m. on 1 December

Announcement of the Open Offer

Β 3 December

Existing Ordinary Shares markedΒ 'ex' by the London Stock Exchange

3Β December

Open Offer Entitlements credit to stock account in CREST of

Qualifying CREST Holders

3Β December

Recommended latest time for requesting withdrawal of Open

Offer Entitlements from CREST

4.30 p.m. on 15 December

Latest time for depositing Open Offer Entitlements into CREST

3.00 p.m. on 16 December

Latest time and date for splitting of Application Forms

(to satisfyΒ bona fideΒ market claims only)

3.00 p.m. on 17 December

Latest time and date for receipt of completed Application FormsΒ 

andΒ payment in full under the Open Offer or settlement or relevant

CREST instruction (as appropriate)

11.00 a.m. on 21 December

Date of Admission and commencement of dealings of the Offer Shares

22 December

Offer Shares creditedΒ to CREST stock accounts

22 December

Date of despatch of definitive share certificates for Offer Shares

29 December

Notes:

(1) References to times in this document are toΒ LondonΒ time (unless otherwise stated).

(2) If any of the above times or dates should change, the revised times and/or dates will be notified by an announcement to an RIS.

(3) The timing of the events in the above timetable and in the rest of this document are indicative only.

3 December 2009

For further information please contact:Β 

Provexis plcΒ  Tel: 01753 752290Β 

Stephen Moon, Chief ExecutiveΒ 

Evolution Securities Tel: 0207 071 4300Β 

Sam PlumptreΒ 

Bobbie Hilliam

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCCKBKPOBDDPBK
Date   Source Headline
5th Jun 20174:35 pmRNSPrice Monitoring Extension
19th May 20174:40 pmRNSSecond Price Monitoring Extn
19th May 20174:35 pmRNSPrice Monitoring Extension
10th May 20177:01 amRNSTrading Update
10th May 20177:00 amRNSResults of Placing
2nd May 20177:15 amRNSFunding Update
11th Apr 20174:40 pmRNSSecond Price Monitoring Extn
11th Apr 20174:35 pmRNSPrice Monitoring Extension
6th Apr 20177:00 amRNSBy-Health MOU and product launch for Fruitflow
8th Feb 20174:40 pmRNSSecond Price Monitoring Extn
8th Feb 20174:35 pmRNSPrice Monitoring Extension
30th Dec 20167:00 amRNSHalf-year Report
21st Dec 20164:41 pmRNSSecond Price Monitoring Extn
21st Dec 20164:35 pmRNSPrice Monitoring Extension
20th Dec 20167:00 amRNSFruitflow and Blood Pressure - second stage update
23rd Nov 20167:00 amRNSStudy publication - comparison with aspirin
18th Nov 20169:46 amRNSNew Collaboration for Fruitflow
30th Sep 20163:33 pmRNSResult of AGM
15th Sep 20165:08 pmRNSDirector/PDMR Shareholding
7th Sep 20167:00 amRNSPreliminary Results
2nd Sep 201610:23 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSResults of Placing
12th Jul 20167:00 amRNSStudy Publication
29th Jun 20167:05 amRNSFunding Update
29th Jun 20167:00 amRNSProduct Launch
9th Jun 20162:29 pmRNSFunding Update
31st May 20167:00 amRNSTrading Update
11th Apr 20164:40 pmRNSSecond Price Monitoring Extn
11th Apr 20164:35 pmRNSPrice Monitoring Extension
25th Feb 20164:40 pmRNSSecond Price Monitoring Extn
25th Feb 20164:35 pmRNSPrice Monitoring Extension
19th Feb 20164:40 pmRNSSecond Price Monitoring Extn
19th Feb 20164:35 pmRNSPrice Monitoring Extension
7th Jan 20162:01 pmRNSDirector/PDMR Shareholding
22nd Dec 20157:00 amRNSHalf Yearly Report
30th Sep 20154:58 pmRNSResult of AGM
7th Sep 201510:47 amRNSAnnual Report and Notice of AGM
4th Sep 20157:00 amRNSPreliminary Results
21st Jul 20153:41 pmRNSHolding(s) in Company
3rd Jul 20157:00 amRNSPlacing of shares via Primarybid.com
29th Jun 20157:00 amRNSUpdate of Collaboration with University of Oslo
4th Jun 20157:00 amRNSEnhanced terms for Fruitflow Alliance Agreement
24th Apr 20154:35 pmRNSPrice Monitoring Extension
20th Feb 20152:34 pmRNSFruitflow - New Product Video
19th Jan 20154:40 pmRNSSecond Price Monitoring Extn
19th Jan 20154:35 pmRNSPrice Monitoring Extension
30th Dec 20147:00 amRNSHalf Yearly Report
9th Dec 20147:00 amRNSDraw Down of Funds and Issue of Equity
1st Dec 20147:00 amRNSRe-appointment to the Scientific Advisory Board
18th Nov 20147:00 amRNSCollaboration with the University of Oslo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.